Brief description of media:

As mortality rates associated with admission to the intensive care unit (ICU) have decreased in recent decades, there has been increasing interest in the long-term negative consequences of critical care. These effects, collectively termed “post-intensive care syndrome,” include emerging or worsening impairments in physical, cognitive, and psychological functioning following ICU admission.

Brief description of media:

Skeletal muscle wasting and weakness are significant complications of critical illness, associated with degree of illness severity and periods of reduced mobility during mechanical ventilation. They contribute to the profound physical and functional deficits observed in survivors. These impairments may persist for many years following discharge from the intensive care unit (ICU) and can markedly influence health‐related quality of life. Rehabilitation is a key strategy in the recovery of patients after critical illness. Exercise‐based interventions are aimed at targeting this muscle wasting and weakness. Physical rehabilitation delivered during ICU admission has been systematically evaluated and shown to be beneficial. However, its effectiveness when initiated after ICU discharge has yet to be established.

Brief description of media:

Long-term follow-up of randomized prospective trials of treatments in the intensive care unit may allow us to attain some understanding of the causes of post-
intensive care syndrome. This in turn may allow us to produce better long-term outcomes among survivors of critical illness.

Brief description of media:

Long-term follow-up of randomized prospective trials of treatments in the intensive care unit may allow us to attain some understanding of the causes of post-intensive care syndrome. This in turn may allow us to produce better long-term outcomes among survivors of critical illness.

Brief description of media:

Long-term follow-up of randomized prospective trials of treatments in the intensive care unit may allow us to attain some understanding of the causes of post intensive care syndrome. This in turn may allow us to produce better long-term outcomes among survivors of critical illness.

Brief description of media:

This midrange theory is derived from Sr. Calista Roy’s adaptation model and Professor Weick’s business model of sensemaking. In his sensemaking model Weick describes that people define themselves through actions taken in crisis. Also, leaders shape the vision of an organization’s well-being through messaging. In facilitated sensemaking, the nurse helps the family to cue sort, and interpret the meaning of those cues in the environment. The nurse provides the family purpose by facilitating individualized engagement in care and praising them for their efforts. Even in the worst of outcomes they can look back and say they did everything possible to help the team. Simple activities provide focus and modulate the limbic system response to stress which may mediate the development of stress disorders.

Brief description of media:

Severe acute respiratory syndrome-corona virus-2, which causes coronavirus disease 2019 (COVID-19), is highly contagious. Airway management of patients with COVID-19 is high risk to staff and patients. We aimed to develop principles for airway management of patients with COVID-19 to encourage safe, accurate and swift performance. This consensus statement has been brought together at short notice to advise on airway management for patients with COVID-19, drawing on published literature and immediately available information from clinicians and experts. Recommendations on the prevention of contamination of health care workers, the choice of staff involved in airway management, the training required and the selection of equipment are discussed. The fundamental principles of airway management in these settings are describedfor: emergency tracheal intubation; predicted or unexpected difficult tracheal intubation; cardiac arrest; anaesthetic care; and tracheal extubation. We providefigures to support clinicians in safe airway managementof patients with COVID-19. The advice in this document is designed to be adapted in line with local workplacepolicies.

Brief description of media:

Considerations for the treatment of oesophageal cancer with radiotherapy during the COVID-19 pandemic.

Brief description of media:

Objective:

The aim was to formulate practice guidelines for determining settings where patients are most likely to benefit from the use of continuous glucose monitoring (CGM).
Participants:

The Endocrine Society appointed a Task Force of experts, a methodologist, and a medical writer.
Evidence:

This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
Consensus Process:

One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, the Diabetes Technology Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.
Conclusions:

The Task Force evaluated three potential uses of CGM: 1) real-time CGM in adult hospital settings; 2) real-time CGM in children and adolescent outpatients; and 3) real-time CGM in adult outpatients. The Task Force used the best available data to develop evidence-based recommendations about where CGM can be beneficial in maintaining target levels of glycemia and limiting the risk of hypoglycemia. Both strength of recommendations and quality of evidence were accounted for in the guidelines.

Brief description of media:

As the 1-year mark of the COVID-19 pandemic approaches, individuals with enduring impairment have become a focus of increasing attention. The term “long COVID” has been used to refer to the estimated 10% of patients with persistent symptoms lasting several weeks or more following acute infection.
These COVID-19 “long haulers,” including cases ranging from mild to severe, have described a wide array of ongoing, unpredictable impairments in physical, cognitive, emotional, and occupational functioning.1 Many patients experience serious effects; for example, preliminary study results suggest that roughly two-thirds of patients incur organ damage. A group of clinicians in the United Kingdom with long COVID have reported new-onset diabetes, cardiovascular disease, and interstitial lung disease, among other effects and conditions, since the time of their infection.

Brief description of media:

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

Brief description of media:

The U.S. Food and Drug Administration ( on April 17, 2020) announced the following actions taken in its ongoing response effort to the COVID-19 pandemic